Chemring's Profit Dips 8% in H1 2026 Despite Sales Growth Amid Heavy Expansion Costs

British defence supplier Chemring Group (LON:CHG) reported a mixed bag of results for the first half of 2026. Although revenue ticked up by 7% to £237.3 million, operating profit fell by 8% to £24.5 million compared to the same period last year. The firm's operating margin shrank to 10.3% from 11.9%, revealing the strain from heavier-than-expected expansion costs.

The sharpest margin deterioration came from Sensors & Information, where operating profit dropped to £9.6 million from £16.1 million, and margins dived to 10.1% from 17.4%. The company pointed to a changing business mix and lower capacity utilisation as key factors behind that contraction.

Chemring's net debt surged, nearing £144.5 million at the end of April 2026, up from £89 million in October 2025. This follows a £44 million investment in capital expenditure aimed at boosting explosives manufacturing capabilities in Chicago, Scotland, and Norway. Management expects these investments to contribute an extra £30 million to operating profits annually, but only starting from 2028.

Chief Executive Michael Ord noted the energetics expansion is progressing briskly: the Chicago site is up and running, Scotland is in the commissioning phase, and Norway is advancing to its next stage. This suggests the company is heavily committed to ramping up production capacity even though current margins are under pressure.

The order book also hit a record high, closing at £1.40 billion-a rise of 8% from a year earlier. Over 90% of Chemring's anticipated revenue for 2026 is already locked in, reinforcing a full pipeline but highlighting the disconnect between sales volume and profitability in the short term.

In its two main business areas, Countermeasures & Energetics remained robust, posting a 31.8% rise in operating profit to £26.1 million on revenue of £142.1 million. This segment is clearly carrying much of the company's profit load amid the hefty expansion outlays.

On the downside, Chemring took an £8.3 million impairment charge related to shutting down its Alloy Surfaces Company in the U.S. after a strategic review concluded insufficient order flow would make continuing operations unviable.

The board increased the interim dividend slightly to 2.8 pence per share from 2.7 pence in the previous period. Notably, the company kept its full-year earnings outlook on hold, suggesting it anticipates margins to improve once new production capacities reach maturity.

The big picture here is a classic defensive sector story: strong underlying demand but short-term profit squeezed due to aggressive investment for future growth. Whether Chemring's expansion pays off as planned will become clearer over the next 1-2 years, especially given the sharp margin drop in its technology arm.